Corcept Therapeutics Inc (NASDAQ: CORT) on Friday, plunged -3.56% from the previous trading day, before settling in for the closing price of $51.69. Within the past 52 weeks, CORT’s price has moved between $20.84 and $62.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12.18% annually for the last half of the decade. The company achieved an average annual earnings per share of 44.68%. With a float of $90.25 million, this company’s outstanding shares have now reached $104.70 million.
In an organization with 352 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 98.44%, operating margin of 22.81%, and the pretax margin is 26.46%.
Corcept Therapeutics Inc (CORT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Corcept Therapeutics Inc is 13.87%, while institutional ownership is 82.24%. The most recent insider transaction that took place on Jan 10 ’25, was worth 111,188. Before that another transaction happened on Jan 02 ’25, when Company’s insider sold 20,000 for $50.39, making the entire transaction worth $1,007,800. This insider now owns 85,318 shares in total.
Corcept Therapeutics Inc (CORT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.68% per share during the next fiscal year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Corcept Therapeutics Inc (CORT) is currently performing well based on its current performance indicators. A quick ratio of 3.64 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.31. Likewise, its price to free cash flow for the trailing twelve months is 36.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.26, a number that is poised to hit 0.38 in the next quarter and is forecasted to reach 1.91 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.73 million. That was inferior than the volume of 0.75 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 41.08%. Additionally, its Average True Range was 2.26.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 57.17%, which indicates a significant increase from 15.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.46% in the past 14 days, which was lower than the 41.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $54.47, while its 200-day Moving Average is $38.67. However, in the short run, Corcept Therapeutics Inc’s stock first resistance to watch stands at $50.81. Second resistance stands at $51.76. The third major resistance level sits at $52.59. If the price goes on to break the first support level at $49.03, it is likely to go to the next support level at $48.20. The third support level lies at $47.25 if the price breaches the second support level.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
Market capitalization of the company is 5.22 billion based on 104,775K outstanding shares. Right now, sales total 482,380 K and income totals 106,140 K. The company made 182,550 K in profit during its latest quarter, and 47,210 K in sales during its previous quarter.
